Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,464 total articles

SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability

SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability

SpyGlass Pharma has acquired Advanced Vision Science, Inc. (AVS) for ~$13 million to secure scalable manufacturing of intraocular lenses (IOLs) for its lead product, the BIM-IOL System, which is in two Phase 3 trials. The acquisition accelerates the company’s ability to develop premium lens options integrated with its sustained drug delivery techno…

Powerus Completes Merger with Aureus Greenway Holdings; Powerus Corporation to Ring Nasdaq Opening Bell, Trading as PUSA

Powerus Completes Merger with Aureus Greenway Holdings; Powerus Corporation to Ring Nasdaq Opening Bell, Trading as PUSA

Powerus Corporation completed its merger with Aureus Greenway Holdings (AGH) effective October 1, 2026, retaining the Nasdaq ticker symbol PUSA. The merger consolidates Powerus as a public company focused on autonomous systems for defense and agriculture markets. Several strategic contracts, partnerships, and manufacturing expansions underpin the c…

NANO Nuclear Energy Advances Vertical Integration Strategy by Signing Definitive Agreement to Acquire Strategic NRC-Licensed U.S. Nuclear Fuel Processing Assets

NANO Nuclear Energy Advances Vertical Integration Strategy by Signing Definitive Agreement to Acquire Strategic NRC-Licensed U.S. Nuclear Fuel Processing Assets

NANO Nuclear Energy Inc. announced a definitive agreement to acquire NRC-licensed U.S. nuclear fuel processing assets, including a license for a depleted uranium hexafluoride deconversion facility in New Mexico. This acquisition advances the company's vertical integration strategy by providing a regulatory and technical foundation to pursue domesti…

Vertex Appoints DataRobot CEO Debanjan Saha to Board of Directors

Vertex Appoints DataRobot CEO Debanjan Saha to Board of Directors

Vertex, Inc., a global leader in indirect tax and compliance solutions, has appointed Debanjan Saha, CEO of DataRobot, to its Board of Directors. Saha brings extensive experience in AI, data, and cloud technologies, positioning Vertex to enhance its AI-first strategy and drive innovation in tax automation and compliance for enterprise clients world…

Aktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519, a Miniprotein Radioconjugate Targeting B7-H3

Aktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519, a Miniprotein Radioconjugate Targeting B7-H3

Aktis Oncology has initiated the Phase 1b BActinium-2 clinical trial to evaluate AKY-2519, a miniprotein radioconjugate targeting B7-H3 expressing tumors such as non-small cell lung cancer (NSCLC). This trial complements the ongoing Phase 1b BActinium-1 trial in metastatic castration-resistant prostate cancer, with preliminary data expected in 2027…

Pasqal Appoints Florence Lao as Chief Legal Officer

Pasqal Appoints Florence Lao as Chief Legal Officer

Pasqal, a Nasdaq-listed leader in neutral-atom quantum computing, announced the appointment of Florence Lao as Chief Legal Officer. Lao brings nearly 20 years of international legal experience to oversee corporate governance, compliance, and strategic growth as Pasqal expands globally.

Alignment Health Expands Access to Personalized Senior Care in 2027 with New Markets, Provider Networks and Medicare Advantage Plan Options

Alignment Health Expands Access to Personalized Senior Care in 2027 with New Markets, Provider Networks and Medicare Advantage Plan Options

Alignment Healthcare announces major expansion of its Medicare Advantage portfolio for 2027, adding coverage in 10 new counties across five states and partnering with prominent providers like Hoag and Astrana Health. The company introduces new culturally connected plans, enhanced pharmacy benefits, and supplemental services, supported by its propri…

nVent Completes Acquisition of Maverick Power

nVent Completes Acquisition of Maverick Power

nVent Electric plc has completed the acquisition of Maverick Power for $1.75 billion, with additional earn-out potential, expanding its power distribution solutions and offerings tailored for data centers. This strategic move enhances nVent's position in the high-growth infrastructure sector by adding new power architectures and system-level soluti…

XPO Opens Two New Service Centers in Fast-Growing Freight Markets

XPO Opens Two New Service Centers in Fast-Growing Freight Markets

XPO, Inc., a leading North American freight transportation company, has opened two new service centers in Mesa, Arizona, and Cameron, Missouri. These new facilities enhance XPO's capacity in the fast-growing Phoenix and Kansas City metropolitan freight markets, supporting increasing demand driven by industrial investment and cross-border trade. The…

Helus Pharma Announces Completion of Legal Name Change

Helus Pharma Announces Completion of Legal Name Change

Helus Pharma, previously known as Cybin Inc., has legally changed its name to reflect its transition from a clinical-stage discovery company to a commercial-ready pharmaceutical company focused on developing novel serotonergic agonists (NSAs) for mental health treatment. The company maintains its listing on Nasdaq and Cboe Canada under the ticker H…

FTI Consulting Appoints Christina Morris as a Senior Managing Director to Expand AI-Enabled Healthcare Capabilities

FTI Consulting Appoints Christina Morris as a Senior Managing Director to Expand AI-Enabled Healthcare Capabilities

FTI Consulting has appointed Christina Morris as a Senior Managing Director in its Healthcare Risk Management & Advisory practice to enhance AI and automation capabilities in healthcare compliance and risk management. Morris brings over 25 years of experience in driving technology-enabled transformations, including AI and hyperautomation, aiming to…

Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD

Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD

Wave Life Sciences announced alignment with FDA on a two-year registrational trial plan for WVE-006, an RNA editing therapy targeting alpha-1 antitrypsin deficiency (AATD). The FDA supports a one-year interim analysis for potential accelerated approval based on biomarkers. WVE-006 aims to treat both lung and liver manifestations of AATD with a subc…

InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development

InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development

InflaRx N.V., a biopharmaceutical company specializing in complement system-targeted anti-inflammatory therapeutics, announced the appointment of Dr. Gabriela Alperovich as Senior Vice President and Global Head of Clinical Development. Dr. Alperovich brings over 20 years of clinical development leadership with expertise in immune-inflammatory and r…

Edible Garden Purchases a 6.2 Acre Building in Webster City, Iowa to Develop 100+ Million Unit Ready-to-Drink Manufacturing Platform

Edible Garden Purchases a 6.2 Acre Building in Webster City, Iowa to Develop 100+ Million Unit Ready-to-Drink Manufacturing Platform

Edible Garden AG Incorporated has entered into a contract to purchase a 6.2-acre property in Webster City, Iowa, to establish its Prairie Hills ready-to-drink (RTD) manufacturing platform. This acquisition transitions the company from tenant to owner, providing greater control over the strategic manufacturing asset aimed at expanding its Farm-to-Fo…

Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting

Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting

Sight Sciences has announced the commercial availability of the OMNI Ultra Surgical System, an advanced next-generation device expanding its pioneering ab interno canaloplasty platform. Showcased at the 2026 American Academy of Ophthalmology meeting, OMNI Ultra enhances procedural versatility and control to treat primary open-angle glaucoma by addr…